Patient-reported outcomes in clinical trials for multiple myeloma: Where we are.

e18615Background: It is recommended to include patient-reported outcomes (PROs) in cancer trials to ensure clinical benefit based on patients’ perceptions. For multiple myeloma patients, PRO measur...